期刊
CANCER RESEARCH
卷 78, 期 8, 页码 1906-1912出版社
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/0008-5472.CAN-17-3287
关键词
-
类别
资金
- National Cancer Institute of the NIH [R01 CA175011]
Despite a greater risk of cancer associated with higher BMI, overweight (BMI 25-<30 kg/m(2)) andclass Iobese (BMI 30-<35 kg/m(2)) patients often have a paradoxically lower risk of overall mortality after a cancer diagnosis, a phenomenon called the obesity paradox. Only when patients exceed a BMI >= 35 kg/m(2) are elevations in mortality risk consistently noted. This paradox has been dismissed as the result of methodologic bias, which we will describe and debate here. However, even if such bias influences associations, there is growing evidence that body composition may in part explain the paradox. This phenomenon may more accurately be described as a BMI paradox. That is, BMI is a poor proxy for adiposity and does not distinguish muscle from adipose tissue, nor describe adipose tissue distribution. Low muscle mass is associated with higher risk of recurrence, overall and cancer-specific mortality, surgical complications, and treatment-related toxicities. Patients with who are overweight or obese have on average higher levels of muscle than their normal-weight counterparts. Also, there is some evidence that patients with moderate levels of subcutaneous adipose tissue may have lower mortality. More research utilizing body composition is needed to clarify the effects of adiposity on cancer mortality. (C) 2018 AACR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据